UK Approves Marstacimab for Severe Haemophilia A or B ...Middle East

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option. Medscape News UK

Read More Details
Finally We wish PressBee provided you with enough information of ( UK Approves Marstacimab for Severe Haemophilia A or B )

Also on site :

• No Way: FBI Assesses That Venezuela Facilitating Migration of Gang Members to US
• ICE arrested Mahmoud Khalil without a warrant, court documents show
• Blue Line service suspended after victim fatally struck by train